Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|October 31, 2019
- Pharmaceutical Technology\'s In the Lab eNewsletter-11-06-2019
- Volume 14
- Issue 11
New 2D Code Reader by Micronic Guarantees Greater Accuracy
The new device guarantees high accuracy code reading through an anti-frost system and a deep-focus image sensor.
Advertisement
The Rack Reader DR700, a new two-dimensional (2D) code reading device by Micronic, an independent manufacturing company located in The Netherlands, guarantees high accuracy code reading through an anti-frost system and a deep-focus image sensor.
The DR700 is designed for fast and accurate sample identification and can scan and decode a rack of data-matrix codes in seven seconds and a single tube of codes in two seconds. It has a small, space-saving benchtop footprint, is compatible with most 2D data-matrix coded tubes, and can be powered with an external power supply or a computer’s USB port.
Additionally, the device features Micronic Code Reader Software and an optional side barcode reader. The software includes an automatic code re-reading function, adjustment controls for brightness, contrast, and threshold, and an automatic code polarity recognition function.
Micronic launched the device in October 2019.
Source:
Articles in this issue
almost 7 years ago
How Best to Select a Quality Cell-Line Sourcealmost 7 years ago
Reviewing the Basic Principles of Dissolution Testingalmost 7 years ago
TetraScience Receives Strategic Investment from Watersalmost 7 years ago
Frontage Expands Bioanalytical Capacity and Capabilitiesalmost 7 years ago
Integra Offers Clear Advantage Product for NGS Library Preparationalmost 7 years ago
MilliporeSigma Launches ADC Express Servicesabout 7 years ago
Novartis Collaborates with Microsoft for AI Innovation LabAdvertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement